Last reviewed · How we verify
Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs
Approved treatments
- Primaxin · Merck Sharp & Dohme B.V.
Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Primaxin · Merck & Co.
Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body. - Recarbrio · Merck & Co.
Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs patent landscape — cliff calendar, originator estates, attackable patents
- Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs treatment landscape brief
- Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs treatment updates RSS
Frequently asked questions about Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs
What drugs treat Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs?
Tracked treatments include Primaxin, Recarbrio.
What is the treatment for Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs?
Standard treatment for Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs includes Primaxin, Recarbrio. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs patent cliff · Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs CI report
- Treatment: Primaxin · Merck Sharp & Dohme B.V.
- Treatment: Primaxin · Merck & Co.
- Treatment: Recarbrio · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing